New research in The New England Journal of Medicine reviews current knowledge on micronutrient requirements, deficiencies, ...

Genomics has long been a primary focus in precision medicine, but other areas of research are increasingly being used to help ...

The pharma giant announced a new partnership with BridGene Biosciences that will use its IMTAC platform for drug discovery.

The global cancer diagnostics market was valued at US$ 163.7 billion in 2021 and is projected to grow at a compound annual ...

Select the journal/section where you want your idea to be submitted: The rapid advancements and decreasing cost of omics technologies such as genomics, epigenomics, transcriptomics, proteomics, ...

Thomas Moehring highlights how advanced technologies such as mass spectrometry, automation and AI are accelerating biomarker ...

The Diagnostic Specialty Enzymes Market was valued at US$ 1.0 billion in 2022 and is projected to grow at a CAGR of 6.9% from ...

This study presents a valuable finding on the importance of the plasma metabolome in glaucoma risk prediction. The authors have used the UK Biobank data to interrogate the association between plasma ...

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East ...

A major population proteomics study using UK Biobank patient samples backed by 14 pharma companies has launched today with the promise of delivering a "transformation" in the study of diseases and ...